BillionaireNet
Afeyan
Noubar Afeyan
Rank #2070
UNITED STATESHealthcareBiotech

Noubar Afeyan

Net Worth
$1.861B
-0.04% (24h)
Noubar Afeyan is an American-Canadian entrepreneur, inventor, and philanthropist. Best known for co-founding Moderna through his venture capital firm, Flagship Pioneering, Afeyan has a net worth of $1.8 billion. His wealth stems from his ventures in the Biotech industry. He has built a successful career, co-founding and developing over 50 life science and technology startups. Afeyan is also recognized for his extensive philanthropic work and has received numerous awards for his contributions to science and society.

The Full Dossier

Early Life

Noubar Afeyan was born in Beirut, Lebanon, in 1962 to Armenian parents. His family fled the Lebanese Civil War and immigrated to Canada in 1975. He graduated from Loyola High School in Montreal in 1978. Afeyan's grandfather survived the Armenian genocide, which influenced his drive and resilience.

Rise to Success

Afeyan earned a B.Eng. in chemical engineering from McGill University in 1983 and a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology (MIT) in 1987. He was the first Ph.D. graduate from MIT's Center for Bioprocess Engineering. Inspired by a meeting with David Packard, Afeyan became an entrepreneur, founding his first biotechnology company in 1987. He co-founded or helped build over 50 life science and technology startups during his career.

Key Business Strategies

Afeyan is the founder and CEO of Flagship Pioneering, a venture capital company established in 2000. Flagship Pioneering creates and develops platform companies, focusing on transformative human health and sustainability products. The firm uses a systematic process to invent and build first-in-category bioplatforms. Flagship has fostered the development of over 100 scientific ventures resulting in over $60 billion in aggregate value. In 2009 Afeyan co-founded Moderna and currently serves as its chairman.

Philanthropy

Afeyan is deeply involved in philanthropy, supporting initiatives particularly in Armenia. He co-founded the Aurora Humanitarian Initiative, which recognizes those who put themselves at risk to save others. He also founded the Afeyan Foundation with his wife, Anna, and supports educational projects, including the UWC Dilijan School. His philanthropic work is driven by a belief in giving back and contributing to a better future. In 2024, Afeyan committed $2 million to support Armenian refugees.

Career Timeline

2025

National Medal of Technology and Innovation

Received the National Medal of Technology and Innovation.

2020

Lecturer at Harvard Business School

Began lecturing at Harvard Business School, continuing to share his knowledge of business and innovation.

2012

Technology Pioneer Award

Received the Technology Pioneer award from the World Economic Forum.

2009

Co-founded Moderna

Co-founded Moderna, a biotechnology company focused on messenger RNA (mRNA) therapeutics.

2000

Senior Lecturer at MIT Sloan School of Management

Began teaching at MIT's Sloan School of Management, sharing his expertise in entrepreneurship and innovation.

1998

Founded Flagship Pioneering

Established Flagship Pioneering, a venture capital firm focused on biotechnology and the creation of new companies.

1987

Founded first biotechnology company

Launched his first biotechnology venture, marking the beginning of a prolific career in the life sciences.

Philanthropic Impact

Humanitarian AidUndisclosed

Aurora Humanitarian Initiative

Co-founded the Aurora Humanitarian Initiative, recognizing those who put themselves at risk to save others.

Education and Humanitarian AidUndisclosed

Afeyan Foundation

Supports programs in education, science & technology and humanitarian action.

EducationUndisclosed

UWC Dilijan School

Supports educational projects in Armenia.

Socio-economic developmentUndisclosed

Afeyan Initiatives for Armenia (AIFA)

Supports socio-economic development projects in Armenia

Wealth Trajectory